These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11964252)

  • 1. Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interactions affects protein folding.
    Zamai M; Hariharan C; Pines D; Safran M; Yayon A; Caiolfa VR; Cohen-Luria R; Pines E; Parola AH
    Biophys J; 2002 May; 82(5):2652-64. PubMed ID: 11964252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature of interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(Carbonyl-bis[imino-N-methyl-4, 2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino] )bis-(1, 3-naphthalene disulfonate).
    Zamai M; Caiolfa VR; Pines D; Pines E; Parola AH
    Biophys J; 1998 Aug; 75(2):672-82. PubMed ID: 9675169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New sulfonated distamycin A derivatives with bFGF complexing activity.
    Ciomei M; Pastori W; Mariani M; Sola F; Grandi M; Mongelli N
    Biochem Pharmacol; 1994 Jan; 47(2):295-302. PubMed ID: 7508230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis.
    Li LY; Safran M; Aviezer D; Böhlen P; Seddon AP; Yayon A
    Biochemistry; 1994 Sep; 33(36):10999-1007. PubMed ID: 7522051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.
    Thompson LD; Pantoliano MW; Springer BA
    Biochemistry; 1994 Apr; 33(13):3831-40. PubMed ID: 8142385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.
    Lam K; Rao VS; Qasba PK
    J Biomol Struct Dyn; 1998 Jun; 15(6):1009-27. PubMed ID: 9669548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two new hydrophobic residues on basic fibroblast growth factor important for fibroblast growth factor receptor binding.
    Zhu H; Ramnarayan K; Menzel P; Miao Y; Zheng J; Mong S
    Protein Eng; 1998 Oct; 11(10):937-40. PubMed ID: 9862214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis.
    Zhu H; Ramnarayan K; Anchin J; Miao WY; Sereno A; Millman L; Zheng J; Balaji VN; Wolff ME
    J Biol Chem; 1995 Sep; 270(37):21869-74. PubMed ID: 7665610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of Arg40 and 45 in the mitogenic activity and structural stability of basic fibroblast growth factor: effects of acidic amino acid substitutions.
    Arakawa T; Holst P; Narhi LO; Philo JS; Wen J; Prestrelski SJ; Zhu X; Rees DC; Fox GM
    J Protein Chem; 1995 Jul; 14(5):263-74. PubMed ID: 8590594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
    Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
    Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of polyoxometalates as inhibitors of basic fibroblast growth factor.
    Pu F; Wang E; Jiang H; Ren J
    Mol Biosyst; 2013 Jan; 9(1):113-20. PubMed ID: 23123725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of FCE 26644 a new growth-factor complexing molecule.
    Sola F; Farao M; Pesenti E; Marsiglio A; Mongelli N; Grandi M
    Cancer Chemother Pharmacol; 1995; 36(3):217-22. PubMed ID: 7781141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alphaT244M mutation affects the redox, kinetic, and in vitro folding properties of Paracoccus denitrificans electron transfer flavoprotein.
    Griffin KJ; Dwyer TM; Manning MC; Meyer JD; Carpenter JF; Frerman FE
    Biochemistry; 1997 Apr; 36(14):4194-202. PubMed ID: 9100014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and characterization of monomeric tryptophan repressor: a model for an early intermediate in the folding of a dimeric protein.
    Shao X; Hensley P; Matthews CR
    Biochemistry; 1997 Aug; 36(32):9941-9. PubMed ID: 9245428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
    Mader JS; Smyth D; Marshall J; Hoskin DW
    Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
    Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R
    Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of high-affinity binding determinants in the receptor binding epitope of basic fibroblast growth factor.
    Zhu H; Anchin J; Ramnarayan K; Zheng J; Kawai T; Mong S; Wolff ME
    Protein Eng; 1997 Apr; 10(4):417-21. PubMed ID: 9194167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic fibroblast growth factor: lysine 134 is essential for its neuroprotective activity.
    Rose K; Kriha D; Pallast S; Junker V; Klumpp S; Krieglstein J
    Neurochem Int; 2007 Jul; 51(1):25-31. PubMed ID: 17524524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
    Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.